Clinical Trial Update: Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis [Phase 4]

View source ↗

Summary

This open-label Phase 4 study evaluated safety and pharmacokinetics of the DUEXIS ibuprofen/famotidine tablet in children with Juvenile Idiopathic Arthritis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• DUEXIS (ibuprofen/famotidine)

Snippet

Sponsor: Amgen | Conditions: Juvenile Idiopathic Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2015-12-23